Sandoz is a global leader in generic pharmaceuticals and biosimilars. As a division of the Novartis Group, their purpose is to discover new ways to improve and extend people’s lives. They contribute to society’s ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. Their portfolio of more than 1000 molecules, covering all major therapeutic areas, accounted for 2015 sales of USD 10.1 billion. In 2015, our products reached more than 500 million patients and we aspire to reach one billion. Sandoz is headquartered in Holzkirchen, in Germany’s greater Munich area.

Mission and Purpose

At Sandoz, they discover new ways to improve and extend people’s lives and pioneer novel approaches to help people around the world access high-quality medicine.

Innovation, Quality and Supply

They have a long history of innovating to increase access to high-quality, affordable medicines to millions of patients around the world.

Sandoz Leadership

Sandoz is led by a diverse team with extensive experience in the generic pharmaceutical and biopharmaceutical industry.

The Sandoz Brand

The Sandoz brand is a seal of quality, and healthcare professionals around the world trust it as a symbol of high-quality, affordable medications.